The Risk and Reversibility of Osimertinib-Related Cardiotoxicity in a Real-World Population. Bak M, Park H, Lee SH, Lee N, et al. J Thorac Oncol 2025;20:167-176.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bak M, Park H, Lee SH, Lee N, et al. The Risk and Reversibility of Osimertinib-Related Cardiotoxicity in a Real-World Population. J Thorac Oncol 2025;20:167-176.
PMID: 39395664